{{Rsnum
|rsid=17679567
|Chromosome=16
|position=76856229
|Orientation=plus
|GMAF=0.1524
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 31.9 | 64.6
| HCB | 0.0 | 2.9 | 97.1
| JPT | 0.0 | 8.8 | 91.2
| YRI | 0.7 | 29.9 | 69.4
| ASW | 0.0 | 35.1 | 64.9
| CHB | 0.0 | 2.9 | 97.1
| CHD | 0.0 | 2.8 | 97.2
| GIH | 3.0 | 14.9 | 82.2
| LWK | 0.0 | 22.9 | 77.1
| MEX | 3.4 | 29.3 | 67.2
| MKK | 0.6 | 23.7 | 75.6
| TSI | 8.8 | 36.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22569225
|Trait=None
|Title=Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNF&#x003b1; inhibitors in patients with rheumatoid arthritis.
|RiskAllele=
|Pval=0.000009
|OR=None
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}